Summary
Cardinal Health, Inc. reported strong financial performance for the nine months ended March 31, 2003, with operating revenue increasing by 13% to $36.96 billion compared to the prior year. Net earnings also saw a significant rise, reaching $1.04 billion for the nine-month period. This growth was driven by increased sales volume across all segments, particularly in Pharmaceutical Distribution and Provider Services, and bolstered by the acquisition of Syncor. The company also reported a substantial $99.6 million gain from litigation settlements related to vitamin antitrust claims, positively impacting the "Other Special Items" category. Despite overall positive trends, the company is managing various restructuring and integration costs associated with recent mergers and acquisitions, totaling $49.3 million for merger-related costs and $18.3 million in other special charges (excluding litigation settlements) during the nine-month period. The balance sheet reflects a significant increase in inventories and trade receivables, contributing to a larger working capital position, while cash and equivalents decreased due to share repurchases. The company maintains a strong liquidity position with an unused $1.5 billion credit facility.
Key Highlights
- 1Total operating revenue for the nine months ended March 31, 2003, increased 13% to $36.96 billion, driven by growth across all segments.
- 2Net earnings for the nine months ended March 31, 2003, rose to $1.04 billion, a significant increase from $759.9 million in the prior year.
- 3The acquisition of Syncor on January 1, 2003, contributed to revenue growth and significant goodwill of $700.4 million.
- 4The company recorded a substantial $99.6 million gain from litigation settlements related to vitamin antitrust claims during the nine months ended March 31, 2003.
- 5Total merger-related costs and other special items (excluding litigation settlements) amounted to $49.3 million and $18.3 million respectively for the nine-month period, reflecting ongoing integration and restructuring efforts.
- 6Inventories increased by approximately $1.4 billion and trade receivables by $550 million, leading to higher overall working capital.
- 7Cardinal Health utilized $1.19 billion for share repurchases during the nine months ended March 31, 2003, leading to a decrease in cash and equivalents.
- 8The company has an undrawn $1.5 billion credit facility, ensuring strong liquidity.